Objectives. The present study was designed to assess the impact of direct current shocks on cardiac troponin I (cTnI), which has greater sensitivity and specificity than creatine kinase (CK) for the diagnosis of myocardial injury.
High energy direct current transthoracic shocks have been reported to cause elevations of total creatine kinase (CK) and CK-MB fraction (CK-MB). Determining whether elevations of CK-MB result from myocardial as opposed to skeletal muscle injury can be difficult (1) (2) (3) (4) . Because there is a higher percentage of CK-MB in myocardial muscle, the measurement of CK-MB as a percentage of total CK has been advocated to improve specificity for cardiac injury. However, this approach has the effect of decreasing sensitivity, especially when concomitant skeletal muscle injury is present (5) (6) (7) (8) .
Cardiac troponin I (cTnI) is a cardiac regulatory protein found only in cardiac muscle (7) . It is a sensitive and specific marker of myocardial injury (7) (8) (9) (10) (11) (12) (13) . Unlike total CK and CK-MB, cTnI is not liberated by skeletal muscle injury. As such, it has been demonstrated to be highly specific for myocardial injury in patients with skeletal muscle injury and chronic renal failure, as well as in the perioperative period (7) (8) (9) (10) (11) (12) (13) . Thus, cTnI should facilitate delineation between skeletal muscle and cardiac injury in patients undergoing cardioversion.
The effect of direct current transthoracic shocks on cTnI values has not been reported. Therefore, diagnostic confusion could result when patients with coronary artery disease receive transthoracic shocks and have elevations of cTnI. Our purpose was to determine if elective transthoracic direct current shocks cause elevations of cTnI levels.
Methods
Patients. A total of 38 patients were studied: 21 patients at the University of Iowa and 17 at Barnes Hospital of Washington University, St. Louis, Missouri. Patients were recruited if they received direct current transthoracic shocks for elective cardioversion (n ϭ 35) or for termination of ventricular tachycardia induced during provocative electrophysiologic testing (n ϭ 3). Patients were excluded from entry into the study if they had a myocardial infarction, unstable angina or a coronary intervention (coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, stent placement or atherectomy) within 10 days of cardioversion, because cTnI levels can remain elevated for over a week after cardiac injury (14) .
Clinical and laboratory evaluations. After written informed consent, the patients' charts were reviewed. Age, gender and major diagnoses were recorded. Baseline CK, CK-MB and cTnI levels were measured. Postshock CK, CK-MB and cTnI levels were obtained at 8, 16, 24 and 48 h when the patient's hospital stay was sufficiently long to allow this.
Standard cardioversion shock energy protocols were followed. Initial selected energies were 50 J for atrial flutter and 100 J for either atrial fibrillation or ventricular tachycardia, with stepwise increases to a maximum of 360 J as judged appropriate by the clinician in charge of the patient's care. All cardioversions were done using Hewlett-Packard defibrillators (various models) with electrodes placed in the apex-anterior or anteroposterior configuration. Either hand-held electrode paddles or self-adhesive monitor-defibrillator electrode pads were used. The type and position of the electrodes used were determined by the clinician in charge of the patient, and was not controlled.
The number of shocks and operator-selected energy given to each patient was recorded. In addition, transthoracic impedance, peak current and actual delivered energy of each shock were recorded in 10 patients studied at the University of Iowa using a Hewlett-Packard "Codemaster" defibrillator that automatically provides this information.
Both CK-MB and cTnI were measured using a Stratus Intellect immunoassay analyzer (Dade). Samples were frozen at Ϫ20°C before analysis and assayed within 12 h of venipuncture. The assays are two-site enzyme immunoassays utilizing monoclonal antibodies to either CK-MB or cTnI. The level of detectability for cTnI is 0.4 ng/ml. The upper limit of the reference range is 0.6 ng/ml (14) .
Statistics. Mean values Ϯ SD were calculated for the main variables; medians were determined for variables with skewed distributions. Pearson correlation coefficients were calculated for linear associations of continuous variables, and Spearman correlation coefficients (rho) for ranked data. To test for the difference in cTnI at baseline and after cardioversion, a paired t test was conducted, followed by repeated measures analysis of variance with adjustment for covariates such as number of transthoracic shocks, peak energy and cumulative energy. The
Wilcoxon signed-rank test was used to test for the difference in CK at baseline and after cardioversion. Alpha was set at 0.05 (two-tailed). All calculations were performed using standard procedures in SYSTAT.
Results
Patients. The clinical characteristics of the patients studied are shown in Table 1 . Patients received from one to five shocks, with one shock being the most frequent (41% of patients) and five the least (3%). The mean (ϮSD) number of shocks was 2.1 Ϯ 1.2. Cumulative energy was positively skewed with a median of 300 J (range 50 to 1,580) ( Table 2 ). Normal sinus rhythm was restored in 32 of 35 patients with atrial fibrillation or atrial flutter and all of the three patients with ventricular tachycardia.
Over half of the patients (62%) experienced an increase in CK after cardioversion. The mean CK increase was 633 Ϯ 1,827 IU/liter; because the data are skewed, the median increase was 9 IU/liter, with a range of Ϫ57 to 1,857 IU/liter ( Table 2 ). The median CK at baseline was 68 IU/liter (range 16 to 647) and the median postcardioversion value was 86 IU/liter (range 20 to 9,025). In four patients, there was an increase of more than 2,000 IU/liter from baseline. The difference in CK from precardioversion to postcardioversion was statistically significant (p ϭ 0.038). However, only one patient had an increase in CK-MB above normal, to 12.7 ng/nl (normal Ͻ6.7).
The relation between cumulative energy and change in CK was not linear but showed evidence of a correlation when ranked (r s ϭ 0.668, p Ͻ 0.001). In the 10 patients in whom current was measured, there was no significant linear relation Abbreviations and Acronyms CK ϭ creatine kinase CK-MB ϭ creatine kinase-MB fraction cTnI ϭ cardiac troponin I (p ϭ 0.458) between peak current and total change in CK, nor was there a significant ranked correlation (r s ϭ 0.595, p Ͼ 0.10). Table 3 shows the peak current, impedance and actual delivered energy in 10 patients undergoing cardioversion at the University of Iowa, using number of shocks with defibrillators to annotate this information.
There was no statistically significant change in cTnI before and after shock (p ϭ 0.276). Adjustment for cumulative energy, peak energy or difference in CK over baseline did not affect this result. Three patients had elevations of cTnI to values of 1.5, 1.2 and 0.8 ng/ml (normal Յ0.6). The patient with a cTnI level of 1.2 ng/ml was also the only patient with an elevated CK-MB. None of these three patients had any clinical events or electrocardiographic evidence to suggest myocardial infarction. These three patients received a mean (ϮSD) of 1.7 Ϯ 1.2) shocks, with a median cumulative energy of 200 IU/liter, similar to all the patients (2.1 Ϯ 1.2 shocks). The peak selected energy of these three patients was 200 Ϯ 100 J), also similar to that of the entire patient group (212 Ϯ 95 J). Two of these three patients had impaired left ventricular systolic function by precardioversion echocardiography compared with 11 of 30 patients who had no cTnI elevation after cardioversion. Left ventricular end-diastolic diameter was normal in all three patients who displayed cTnI elevation after cardioversion.
Discussion
The major finding of our study is that minor elevations of cTnI reflecting subtle myocardial injury can occur during elective cardioversion, but they are uncommon. Substantial elevations of cTnI do not occur.
Three of our patients showed cTnI elevations; 35 of our 38 patients did not. However, we were careful to exclude patients with cardiac events in the 10 days before cardioversion because elevations of troponin persist in plasma for a median of 7 days after myocardial injury (14) . We also insisted that each patient have a normal baseline value of cTnI. Unless such precautions are followed, cTnI elevations are likely to be encountered more frequently and may be of a larger magnitude.
Elevations of total CK were common and were significantly increased after cardioversion, with a mean increase of 633 Ϯ 1,827 IU/liter over baseline. This is not unexpected and is consistent with previous reports of high CK values after high energy transthoracic shocks (1-3). However, of the three patients with cTnI elevations, CK-MB values were elevated in only one. This patient had no clinical symptoms or electrocardiographic evidence of infarction, but did have impaired left ventricular systolic function by precardioversion echocardiography. He received three shocks totaling 600 J, which terminated his atrial fibrillation.
A second patient had an elevated cTnI level of 1.5 ng/ml at 24 h and 1.3 ng/ml at 48 h. He was admitted to the hospital for severe congestive heart failure requiring inotropic support and was in atrial fibrillation. He had received one successful 200-J shock. He did not have a significant increase in CK-MB or clinical or electrocardiographic evidence of infarction. The reason for his elevated value of cTnI is likely multifactorial. Recent data suggest that patients with congestive heart failure have higher levels of cTnI than normal subjects. Missov et al. (15) studied 11 patients with end-stage congestive heart failure and found circulating levels of cTnI in 10, levels which were higher than those of any of their control subjects. However, all of them had levels of cTnI below the level of detection of the assay used for this study. Nonetheless, patients with congestive heart failure may have subtle ongoing myocardial injury that might make them more susceptible to damage induced by direct current shock energy. Two of our patients with increased cTnI had impaired left ventricular function by echocardiography, and one, as noted, had clinical congestive heart failure.
The final patient with an elevation of cTnI did not have heart failure or any other reason for an elevated cTnI apart from the direct current shock. He received one shock of 100 J, which terminated his atrial flutter.
Current and impedance measurements were not available from any of the three patients with cTnI elevations; we cannot exclude the possibility that these three patients had lower transthoracic impedance and thus received more current than the others.
The fact that minor degrees of myocardial injury can be induced by electrical shocks should not be surprising. Myocardial injury has been demonstrated after direct current shocks both histologically and by enzyme analysis in experimental studies (1) (2) (3) (4) . The mechanism of this injury is uncertain. Heat-induced necrosis has been suggested as a possible cause (16), but is not universally accepted (17) . Electroporation (the increase in permeability of the cellular membrane in response to pulsed electric fields) occurs after direct current shocks, and it too has been proposed as a potential mechanism (17) . Electroporation has been shown to be dependent on pulse duration, voltage, number of pulses applied and time between pulses (18). In addition, a reduction in mitochondrial oxygen consumption after direct current shocks has been observed and hypothesized to be due to intracellular calcium flux, high circulating catecholamines or free radical generation (18) . However, pretreatment with beta-blockers and calcium channel blockers does not reduce direct current shock-induced myocardial damage (19) . Free radicals, which are known to be toxic to the myocardium, also are known to be generated by direct current shocks (20) . Caterine et al. (20) showed that free radical generation was proportional to the magnitude of the shock energy and that the free radical scavengers superoxide dismutase and catalase reduced this free radical generation (21). Thus, regardless of the mechanism, minor degrees of myocardial injury were not unexpected. Elevations of cTnI in patients with acute infarction. Importantly, these minor cTnI elevations should not lead to diagnostic confusion with possible ischemic cardiac injury. In a recent series of 163 patients with acute infarction, the mean peak cTnI value ranged from 7.7 to 33.7 ng/ml depending on the type of infarction. Although there was an occasional patient with a mean value Ͻ1 ng/ml among patients with non-Q wave infarction, such minor elevations were rare (14) . Accordingly, elevations Ͼ1.5 ng/ml (the highest value in our series) should be considered indicative of cardiac injury from a cause other than the elective cardioversion.
Previous studies of cardioversion. A positive relation between total CK increase and cumulative energy has been noted previously (2,3), but not consistently (1). We did not observe a linear relation, but we did find a significant positive correlation when the data were ranked. Although this may in part be due to low patient numbers, it is clear that the relation between CK release from skeletal and cardiac muscle and direct current shocks is dependent on many variables in addition to shock energy. For example, Dahl et al. (22) demonstrated that the shorter the time between successive shocks, the greater the myocardial damage. Furthermore, for transthoracic defibrillation, greater myocardial damage occurs when using smaller electrode sizes (23) . Some, if not all, of these principles may apply to skeletal muscle injury as well. Therefore, it is not surprising that a high correlation between cumulative energy and CK increase was not observed.
Our findings with regard to CK-MB after cardioversion are similar to those of other investigators. Ehsani et al. (1) studied 35 patients receiving direct current countershocks. They found that 50% of their patients had an elevated peak CK, whereas only two patients had modest elevations of CK-MB. They concluded that "conventionally used countershock does not produce myocardial damage, although myocardial injury sufficient to release small amount of MB creatine kinase into the circulation appears to occur occasionally" (1) . Unfortunately, at the time of that study, techniques such as the use of cTnI were not available to help distinguish skeletal muscle from cardiac muscle release of CK-MB.
Jakobsson et al. (2) studied 30 patients cardioverted for atrial fibrillation. Seven of them had elevations of CK-MB. None of these seven patients had an elevation of the CK-MB to CK ratio, which is a criterion that improves the specificity for CK-MB release for cardiac injury, but at the expense of sensitivity. Metcalfe et al. (4) examined 25 patients cardioverted for atrial fibrillation. Creatine kinase, MB fraction was elevated in six patients, "appreciably so" in only two patients. These two patients also had a high total CK, and thus a low percentage of CK-MB relative to total CK.
Although experimental studies have shown that myocardial damage increases with increasing shock strength (16) , there was no correlation in our data set between peak current and total CK increase in the 10 patients in whom current was measured. In addition, the three patients with elevated cTnI levels received numbers of shocks and cumulative and peak energies similar to those of the patients without cTnI elevations.
Conclusions. Three of 38 patients undergoing elective cardioversion had mildly elevated cTnI levels after the procedure. The fact that there is no cross reactivity between cTnI and skeletal muscle troponin I means that these elevations were due to subtle degrees of myocardial injury. However, these minor postcardioversion elevations should not mask concomitant myocardial infarction or cause diagnostic confusion; substantial elevation of cTnI after defibrillation should suggest the presence of myocardial injury from causes unrelated to direct current shocks.
